The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Potential Therapeutic Benefits of Strategies Directed to Mitochondria
Open accessAbstract
The mitochondrion is the most important organelle in determining continued cell survival and cell death. Mitochondrial dysfunction leads to many human maladies, including cardiovascular diseases, neurodegenerative disease, and cancer. These mitochondria-related pathologies range from early infancy to senescence. The central premise of this review is that if mitochondrial abnormalities contribute to the pathological state, alleviating the mitochondrial dysfunction would contribute to attenuating the severity or progression of the disease. Therefore, this review will examine the role of mitochondria in the etiology and progression of several diseases and explore potential therapeutic benefits of targeting mitochondria in mitigating the disease processes. Indeed, recent advances in mitochondrial biology have led to selective targeting of drugs designed to modulate and manipulate mitochondrial function and genomics for therapeutic benefit. These approaches to treat mitochondrial dysfunction rationally could lead to selective protection of cells in different tissues and various disease states. However, most of these approaches are in their infancy. Antioxid. Redox Signal. 13, 279–347. Introduction and Topics Reviewed Anatomy and Function of Mitochondrial Membranes Outer mitochondrial membrane and its potential role as therapeutic target Inner mitochondrial membrane and its potential role as therapeutic target Mitochondrial permeability transition pore Electron Transport Chain and Oxidative Phosphorylation: Modulation by Mitochondrial Ion Channels and Exchangers Mitochondrial ROS and RNS Mitochondria and reactive oxygen species Mitochondria and reactive nitrogen species Mitochondrial ROS Scavenging and Its Potential Therapeutic Value Manganese superoxide dismutase Glutathione thioredoxin, and peroxiredoxin systems Catalase and glutathione peroxidase Cytochrome c Mitochondria as scavengers of cytosolic O2•− Uncoupling Proteins in Modulation of Mitochondrial Function: Physiological and Pharmacologic Relevance Mitochondrial DNA-Related Pathologies and a Potential Therapeutic Target Mitochondrial Interaction with other Organelles: Therapeutic Implications Mitochondrion—mitochondrion interaction Mitochondrion—nucleus interaction Mitochondria—endoplasmic/sarcoplasmic reticulum interaction Mitochondria-Related Diseases and Cell Injury Mitochondria and cardiac ischemia and reperfusion injury Mitochondria and the failing heart Mitochondria and diabetes Mitochondria and hypertension Mitochondria and neurodegenerative diseases Alzheimer's disease Parkinson's disease Amyotrophic lateral sclerosis Friedreich's ataxia Neoplastic diseases Other mitochondria-related diseases Mitochondria and psychiatric disorders Mitochondria and migraine headache Mitochondrial Pharmacology and Therapeutic Potential Strategies for drug delivery to mitochondria Mitochondria-targeted drugs Approaches to improve mitochondrial function during ischemia and reperfusion Preconditioning Postconditioning Other Mitochondrial Therapeutic Approaches Lipid replacement therapy Transactivator of transcription proteins and mitochondrial therapy Molecular genetics approaches Mitochondria and caloric restriction Mitochondria and dietary supplements Mitochondria Age and Lifespan Mitochondria and age-associated diseases Mitochondrial p66shc and lifespan Caveats and Potential Limitations in Mitochondrial Drug Targeting Conclusion and Perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 5×
“For example, isolated mitochondria supplemented with GPDH can produce O2 from complex I to the matrix side and some from the cytosolic side (20, 345) (Fig.”
BackgroundMethodInfluentialMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 6×
“Bcl-2 and Bcl-Xl also interact with sensitizer BH3-only domain peptides including Bcl-2-associated death proteins (Bad), Bcl-2-interacting killer (Bik) protein, and perhaps Bcl-2=adenovirus E1B 19 kdinteracting protein (Bnip).”
BackgroundInfluentialRapid evolution of animal mitochondrial DNA
Brown, W. M., George, M., & Wilson, A. C. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.4.1967 · Cited by 3,439
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575
Mitofusin 2 tethers endoplasmic reticulum to mitochondria
de Brito, O. M., & Scorrano, L. (2008) · Nature · doi:10.1038/nature07534 · Cited by 2,442
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 2×
“For example, metformin (N(1),N(1)dimethylbiguanide), an antidiabetic drug, blocks complex I of the ETC because it accumulates in the matrix (427).”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789
Endonuclease G is an apoptotic DNase when released from mitochondria
Li, L. Y., Luo, X., & Wang, X. (2001) · Nature · doi:10.1038/35083620 · Cited by 1,787 · cited 1×
“Endo G is a mitochondria-specific nuclease that once released from mitochondria translocates to the nucleus and cleaves DNA into nucleosomal fragments independent of caspases (336).”
BackgroundExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724
Production of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
Self-citationTopology of superoxide production from different sites in the mitochondrial electron transport chain
St-Pierre, J., Buckingham, J. A., Roebuck, S. J., & Brand, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207217200 · Cited by 1,545
Reactive Oxygen Species (Ros-Induced) Ros Release
Zorov, D. B., Filburn, C. R., Klotz, L.-O., Zweier, J. L., & Sollott, S. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1001 · Cited by 1,412
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 2×
“It is noteworthy that at an early stage of AD there is already a reduced number of mitochondria (247, 257), brain glucose metabolism is decreased (247, 287), and the activities of TCA cycle enzymes (79, 520) and cytochrome c oxidase are reduced (97, 247, 441) while there is enhanced cytochrome c release (177, 296), mP…”
BackgroundActivation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
An ER-Mitochondria Tethering Complex Revealed by a Synthetic Biology Screen
Kornmann, B., Currie, E., Collins, S. R., Schuldiner, M., Nunnari, J., Weissman, J. S., & Walter, P. (2009) · Science · doi:10.1126/science.1175088 · Cited by 1,275 · cited 3×
“Since mitochondria are not connected to other organelles through vesicular trafficking pathways, mitochondria–ER communication is via discrete sites of close apposition that would facilitate lipid and Ca2þ exchange between the organelles (308).”
BackgroundGeneration of reactive oxygen species by the mitochondrial electron transport chain
Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260 · cited 1×
“These include monoamine oxidase and cytochrome b5 reductase in the OMM (85), in the IMM along the ETC (63, 64, 316, 347, 536, 580, 656), in the TCA cycle from a-ketoglutarate dehydrogenase and aconitase, and from nonTCA cycle enzymes, pyruvate dehydrogenase and glycerol3-phosphate dehydrogenase (GPDH) (335).”
BackgroundAnderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253 · cited 1×
“It is noteworthy that both mitochondria-targeted catalase and SS-31 preserved insulin sensitivity by preventing mitochondrial oxidative stress induced by high fat diet in rodents (15).”
BackgroundMitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission.
Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., & Mihara, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607279200 · Cited by 1,226
Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
Turrens, J. F., Alexandre, A., & Lehninger, A. L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90293-0 · Cited by 1,214 · cited 3×
“These include monoamine oxidase and cytochrome b5 reductase in the OMM (85), in the IMM along the ETC (63, 64, 316, 347, 536, 580, 656), in the TCA cycle from a-ketoglutarate dehydrogenase and aconitase, and from nonTCA cycle enzymes, pyruvate dehydrogenase and glycerol3-phosphate dehydrogenase (GPDH) (335).”
BackgroundSelective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
The role of exercise and PGC1α in inflammation and chronic disease
Handschin, C., & Spiegelman, B. M. (2008) · Nature · doi:10.1038/nature07206 · Cited by 1,083
A mitochondrial specific stress response in mammalian cells
Zhao, Q., Wang, J., Levichkin, I. V., Stasinopoulos, S., Ryan, M. T., & Hoogenraad, N. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf445 · Cited by 1,026
Lebovitz, R. M., Zhang, H., Vogel, H., Cartwright, J., Dionne, L., Lu, N., Huang, S., & Matzuk, M. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9782 · Cited by 1,023
Cadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855
Properties of the Permeability Transition Pore in Mitochondria Devoid of Cyclophilin D
Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A., & Bernardi, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500089200 · Cited by 808 · cited 1×
“The role of CypD in the regulation of cell survival or death is evidenced by the finding that cells from mice lacking the Ppif gene that encodes the protein are protected from necrotic caspase-independent cell death but not from caspase-dependent apoptosis (36, 43, 297).”
BackgroundMutagenesis by 8-oxoguanine: an enemy within
Grollman, A. P., & Moriya, M. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90089-z · Cited by 807 · cited 1×
“For example, there was observed an increase in 8oxoguanine, a common marker of DNA lesion resulting from ROS, in the motor cortex, spinal cord, and plasma of these patients (222, 634).”
BackgroundDevi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-06.2006 · Cited by 792
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710
Skulachev, V. P. (1996) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500005795 · Cited by 703 · cited 27×
“This generates a pH gradient and an electrostatic potential, DCm, across the IMM.”
BackgroundInfluentialElchuri, S., Oberley, T. D., Qi, W., Eisenstein, R. S., Jackson Roberts, L., Van Remmen, H., Epstein, C. J., & Huang, T.-T. (2005) · Oncogene · doi:10.1038/sj.onc.1208207 · Cited by 667 · cited 1×
“(321, 340), whereas the CuZnSOD (extra-matrix SOD) gene knockout was not, though lifespan was shortened (183) and oxidative stress was elevated (389).”
BackgroundResponse to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy
Hamacher-Brady, A., Brady, N. R., Logue, S. E., Sayen, M. R., Jinno, M., Kirshenbaum, L. A., Gottlieb, R. A., & Gustafsson, Å. B. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401936 · Cited by 609
Webb, A., Bond, R., McLean, P., Uppal, R., Benjamin, N., & Ahluwalia, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402927101 · Cited by 608 · cited 1×
“In isolated rat heart experiments it was shown that reduction of nitrite to NO during ischemia protects against myocardial damage (611).”
BackgroundIs the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Ingwall, J. S., & Weiss, R. G. (2004) · Circulation Research · doi:10.1161/01.res.0000137170.41939.d9 · Cited by 604 · cited 1×
“In the extreme, the work capacity of the heart is limited not by the availability of metabolic substrates or O2, but by the impaired ability to consume the available substrates (267, 539).”
BackgroundCytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · cited 1×
“It is noteworthy that at an early stage of AD there is already a reduced number of mitochondria (247, 257), brain glucose metabolism is decreased (247, 287), and the activities of TCA cycle enzymes (79, 520) and cytochrome c oxidase are reduced (97, 247, 441) while there is enhanced cytochrome c release (177, 296), mP…”
BackgroundMitochondrial Energetics in the Heart in Obesity-Related Diabetes
Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J. J., Hu, X. X., Aziz, S., Johnson, J. I., Bugger, H., Zaha, V. G., et al. (2007) · Diabetes · doi:10.2337/db07-0481 · Cited by 586
PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells
VALLE, I., ALVAREZBARRIENTOS, A., ARZA, E., LAMAS, S., & MONSALVE, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.026 · Cited by 556
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I
Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1052 · Cited by 521
Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia
Wright, E., Scism-Bacon, J. L., & Glass, L. C. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00825.x · Cited by 517 · cited 1×
“Undeniably, mitochondrial ROS production and the concomitant oxidative damage may contribute to the onset and progression of both types 1 and 2 diabetes (280, 627).”
BackgroundDeletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans
Van Raamsdonk, J. M., & Hekimi, S. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000361 · Cited by 511
Lambert, A. J., & Brand, M. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406576200 · Cited by 480
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480 · cited 5×
“Other drugs, such as trimetazidine, commonly prescribed as an anti-angina drug (68, 171), and ranolazine (currently being tested for its effect on heart failure) directly inhibit b-oxidation enzymes and potentially other metabolic enzymes (68, 538).”
BackgroundResultInfluentialSelective targeting of an antioxidant to mitochondria
Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466
Mitochondrial H + Leak and ROS Generation: An Odd Couple
Brookes, P. S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.016 · Cited by 447
AZOULAY-ZOHAR, H., ISRAELSON, A., ABU-HAMAD, S., & SHOSHAN-BARMATZ, V. (2004) · Biochemical Journal · doi:10.1042/bj20031465 · Cited by 408 · cited 32×
“A model structure of the mPTP put forward by Halestrap et al. (236, 237) and Di Lisa and Bernadi (161) involves the combination of the adenine nucleotide translocase (ANT) in the IMM, the VDAC of the OMM, and a regulatory protein cyclophilin D (CypD) in the matrix (Fig.”
BackgroundInfluentialChae, H. Z., Kim, H. J., Kang, S. W., & Rhee, S. G. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00037-6 · Cited by 390
The role of mitochondria in protection of the heart by preconditioning
Halestrap, A. P., Clarke, S. J., & Khaliulin, I. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.05.008 · Cited by 390 · cited 2×
“Adenine nucleotides, Mg2þ, and matrix Hþ inhibit the pore (71, 177, 236, 237, 411).”
BackgroundSelective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080362 · Cited by 332
KATP channel‐independent targets of diazoxide and 5‐hydroxydecanoate in the heart
Hanley, P. J., Mickel, M., Löffler, M., Brandt, U., & Daut, J. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.023960 · Cited by 320
Uncoupling Protein-2 Overexpression Inhibits Mitochondrial Death Pathway in Cardiomyocytes
Teshima, Y., Akao, M., Jones, S. P., & Marbán, E. (2003) · Circulation Research · doi:10.1161/01.res.0000085581.60197.4d · Cited by 318 · cited 1×
“However, high m[Ca2þ], as observed during cardiac I=R, can impair ATP synthesis and lead to a loss of ion homeostasis, opening of the mPTP, matrix swelling, and OMM rupture (277, 569).”
BackgroundCell-permeable, mitochondrial-targeted, peptide antioxidants
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1007/bf02854898 · Cited by 316
Rathore, R., Zheng, Y.-M., Niu, C.-F., Liu, Q.-H., Korde, A., Ho, Y.-S., & Wang, Y.-X. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.012 · Cited by 283
Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E., & Shoshan-Barmatz, V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708216200 · Cited by 278 · cited 23×
“In OXPHOS, electrons are transferred from NADH and FADH2 to molecular O2 through the ETC complexes I–IV until two electrons and two protons combine with ½O2 to produce H2O at complex IV (respiration).”
BackgroundInfluentialCadenas, E., & Boveris, A. (1980) · Biochemical Journal · doi:10.1042/bj1880031 · Cited by 275
Kevin, L. G., Camara, A. K. S., Riess, M. L., Novalija, E., & Stowe, D. F. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00711.2002 · Cited by 272
Self-citationKimura, S., Zhang, G.-X., Nishiyama, A., Shokoji, T., Yao, L., Fan, Y.-Y., Rahman, M., Suzuki, T., Maeta, H., & Abe, Y. (2005) · Hypertension · doi:10.1161/01.hyp.0000163462.98381.7f · Cited by 264 · cited 1×
“Extra-mitochondrial sources of ROS including NAD(P)H oxidase (219, 299, 624) and xanthine oxidase in vasculature (46, 571) are other likely sources of ROS.”
BackgroundSelective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids
Taylor, R. W., Chinnery, P. F., Turnbull, D. M., & Lightowlers, R. N. (1997) · Nature Genetics · doi:10.1038/ng0297-212 · Cited by 249 · cited 1×
“Mitochondrial disorders of the heteroplasmic type and the associated disease could be remedied by selectively blocking the replication of mutant DNA molecules to allow repopulation of the wild-type mtDNA (567).”
BackgroundMitochondrial changes associated with glutathione deficiency
Meister, A. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00007-q · Cited by 242
HANLEY, P., & DAUT, J. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.04.002 · Cited by 218
Killing cancer cells by flipping the Bcl-2/Bax switch
Cory, S., & Adams, J. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.012 · Cited by 217 · cited 1×
“Thus these Bcl family proteins appear to be attractive therapeutic targets in fighting neoplastic cells (4, 131).”
BackgroundUbiquitous overexpression of CuZn superoxide dismutase does not extendlife span in mice
(2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.1.b5 · Cited by 216 · cited 1×
“In marked contrast, a SOD2 (MnSOD) knockout results in neonatal lethality (263, 264) due to dilated ventricular cardiomyopathy, fibrosis, and other complications (20, 145, 262–264).”
BackgroundBenton, C. R., Nickerson, J. G., Lally, J., Han, X.-X., Holloway, G. P., Glatz, J. F. C., Luiken, J. J. F. P., Graham, T. E., Heikkila, J. J., & Bonen, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704332200 · Cited by 214 · cited 1×
“Overexpression of PGC-1a in mouse skeletal muscle increased glucose as well as the expression of proteins that are involved in fat oxidation and glucose transport (52).”
BackgroundWenzel, P., Schuhmacher, S., Kienhöfer, J., Müller, J., Hortmann, M., Oelze, M., Schulz, E., Treiber, N., Kawamoto, T., Scharffetter-Kochanek, K., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn182 · Cited by 207 · cited 2×
“Certainly, increased oxidative stress has been associated with increased mtDNA strand breaks during aging and in the aged MnSOD-deficient mice (614).”
BackgroundOpening mitochondrial K ATP in the heart - what happens, and what does not happen
Garlid, K. D. (2000) · Basic Research in Cardiology · doi:10.1007/s003950070046 · Cited by 186
Mitochondrial proton leak and the uncoupling protein 1 homologues
Stuart, J. A., Cadenas, S., Jekabsons, M. B., Roussel, D., & Brand, M. D. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00243-7 · Cited by 169
Vanden Hoek, T. L., Shao, Z., Li, C., Schumacker, P. T., & Becker, L. B. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0481 · Cited by 161 · cited 2×
“This subject is discussed in greater detail in our recent review article (543), and by others (14, 591, 592), and will not be covered in any more detail here.”
BackgroundCytochrome c, an ideal antioxidant
Pereverzev, M. O., Vygodina, T. V., Konstantinov, A. A., & Skulachev, V. P. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311312 · Cited by 150
RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila
Anderson, P. R., Kirby, K., Hilliker, A. J., & Phillips, J. P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi367 · Cited by 144 · cited 1×
“melanogaster has yielded the opposite outcome, that is, lifespan was decreased instead of increased (16).”
BackgroundNadtochiy, S. M., Baker, P. R. S., Freeman, B. A., & Brookes, P. S. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn323 · Cited by 131
The role of mitochondria in ageing and carcinogenesis
Birch-Machin, M. A. (2006) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2006.02161.x · Cited by 130 · cited 2×
“A growing body of evidence suggests that tumor cells exhibit increased intrinsic ROS stress due in part to oncogenic stimulation, increased metabolic activity, and mitochondrial dysfunction (56).”
BackgroundEffect of Cytochrome c on the Generation and Elimination of O2⨪ and H2O2 in Mitochondria
Zhao, Y., Wang, Z.-B., & Xu, J.-X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209681200 · Cited by 129
Amyloid ?? peptide induces cytochrome c release from isolated mitochondria
Kim, H.-S., Lee, J.-H., Lee, J.-P., Kim, E.-M., Chang, K.-A., Park, C. H., Jeong, S.-J., Wittendorp, M. C., Seo, J.-H., Choi, S.-H., et al. (2002) · NeuroReport · doi:10.1097/00001756-200210280-00032 · Cited by 124
Chen, Q., & Lesnefsky, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.043 · Cited by 119
Self-citationRiess, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.016 · Cited by 118
Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes
MacDonald, M. J., Longacre, M. J., Langberg, E.-C., Tibell, A., Kendrick, M. A., Fukao, T., & Ostenson, C.-G. (2009) · Diabetologia · doi:10.1007/s00125-009-1319-6 · Cited by 115
Su, Y. A., Wu, J., Zhang, L., Zhang, Q., Su, D. M., He, P., Wang, B.-D., Li, H., Webster, M. J., Group, T. S. B. S., et al. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.223 · Cited by 113
Mitochondrial DNA mutations and aging: devils in the details?
Khrapko, K., & Vijg, J. (2009) · Trends in Genetics · doi:10.1016/j.tig.2008.11.007 · Cited by 112
Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases
Szeto, H. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.013 · Cited by 100
Caloric restriction protects mitochondrial function with aging in skeletal and cardiac muscles
Hepple, R. T., Baker, D. J., McConkey, M., Murynka, T., & Norris, R. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.219 · Cited by 94 · cited 4×
“It was reported that the rate of decline of PGC-1a was lower in CR animals than in non-CR animals (255).”
BackgroundInfluentialThomas, D. A., Stauffer, C., Zhao, K., Yang, H., Sharma, V. K., Szeto, H. H., & Suthanthiran, M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080825 · Cited by 84
Iñarrea, P., Moini, H., Han, D., Rettori, D., Aguiló, I., Alava, M. A., Iturralde, M., & Cadenas, E. (2007) · Biochemical Journal · doi:10.1042/bj20061809 · Cited by 73
Gutteridge, J. M. C. (1990) · Free Radical Research Communications · doi:10.3109/10715769009148579 · Cited by 71
Zoccarato, F., Cavallini, L., Bortolami, S., & Alexandre, A. (2007) · Biochemical Journal · doi:10.1042/bj20070215 · Cited by 66 · cited 2×
“When FADH2-related substrates are used and electrons enter the ETC at complex II, O2 may be generated by reverse electron transfer to the FMN site of complex I (113, 543, 656).”
BackgroundAzzu, V., Parker, N., & Brand, M. D. (2008) · Biochemical Journal · doi:10.1042/bj20080321 · Cited by 52
Absence of Nitric-oxide Synthase in Sequentially Purified Rat Liver Mitochondria
Venkatakrishnan, P., Nakayasu, E. S., Almeida, I. C., & Miller, R. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003301 · Cited by 52
Cytochrome C is a Hydrogen Peroxide Scavenger in Mitochondria
Wang, Z.-B., Li, M., Zhao, Y., & Xu, J.-X. (2003) · Protein & Peptide Letters · doi:10.2174/0929866033479013 · Cited by 43 · cited 1×
“It was shown that addition of exogenous cytochrome c to cytochrome c-depleted mitochondria reduced O2 levels by 7–8-fold (609, 652).”
BackgroundCamara, A. K. S., Aldakkak, M., Heisner, J. S., Rhodes, S. S., Riess, M. L., An, J., Heinen, A., & Stowe, D. F. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00231.2006 · Cited by 42
Self-citationA transgenic model to study the pathogenesis of somatic mtDNA mutation accumulation in β‐cells
Bensch, K. G., DeGraaf, W., Hansen, P. A., Zassenhaus, H. P., & Corbett, J. A. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00776.x · Cited by 12
Cited by
Reperfusion injury and reactive oxygen species: The evolution of a concept
Granger, D. N., & Kvietys, P. R. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.020 · Cited by 1,484
Monogenic Mitochondrial Disorders
Koopman, W. J. H., Willems, P. H. G. M., & Smeitink, J. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1012478 · Cited by 522
Impaired mitochondrial function in psychiatric disorders
Manji, H., Kato, T., Di Prospero, N. A., Ness, S., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3229 · Cited by 483
Rogers, G. W., Brand, M. D., Petrosyan, S., Ashok, D., Elorza, A. A., Ferrick, D. A., & Murphy, A. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021746 · Cited by 478
Figueira, T. R., Barros, M. H., Camargo, A. A., Castilho, R. F., Ferreira, J. C. B., Kowaltowski, A. J., Sluse, F. E., Souza-Pinto, N. C., & Vercesi, A. E. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4729 · Cited by 419
Metadata
- Authors
- Camara, A. K. S., Lesnefsky, E. J., & Stowe, D. F.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2010-08
- Volume
- 13
- Issue
- 3
- Pages
- 279-347
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2090217381
- Cited by
- 194
- References
- 95
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.